Abstract
Capillary electrophoresis (CE) was used to follow Diclofenac tablet dissolution, in very short times and allowing dissolution testing without volume replacement. By using Student´s t test and F-test, this CE method was compared with HPLC. Statistical data show that there are no significant differences among them. The drug release kinetic of diclofenac tablets was described by various mathematical models and equations. Model-Independent Methods: t50% = 10.34 min; t80% = 20 min; DE% = 79.41% and MDT = 10.85 min, show that diclofenac tablet dissolution rate is very high, having 80% drug dissolution within 20 minutes. Model-Dependent Methods. The kinetics models used were: zero order, first order, Hixson–Crowell cube root law, Higuchi model, and Weibull model. Criteria used to choose the best model was by comparisson of r2 and AIC (Akaike Information Criteria). The model that best adjusts diclofenac tablet dissolution profile was the Hixson-Crowell cube root model.
Keywords: Capillary electrophoresis, diclofenac, dissolution, Hixson-Crowell, quantification, tablets.
Current Pharmaceutical Analysis
Title:Fast and Efficient Monitoring of Diclofenac Dissolution Profile by CE
Volume: 10 Issue: 1
Author(s): Celina M. Monzon, Luciana Vera-Candioti, María del C. Sarno and Mario R. Delfino (h)
Affiliation:
Keywords: Capillary electrophoresis, diclofenac, dissolution, Hixson-Crowell, quantification, tablets.
Abstract: Capillary electrophoresis (CE) was used to follow Diclofenac tablet dissolution, in very short times and allowing dissolution testing without volume replacement. By using Student´s t test and F-test, this CE method was compared with HPLC. Statistical data show that there are no significant differences among them. The drug release kinetic of diclofenac tablets was described by various mathematical models and equations. Model-Independent Methods: t50% = 10.34 min; t80% = 20 min; DE% = 79.41% and MDT = 10.85 min, show that diclofenac tablet dissolution rate is very high, having 80% drug dissolution within 20 minutes. Model-Dependent Methods. The kinetics models used were: zero order, first order, Hixson–Crowell cube root law, Higuchi model, and Weibull model. Criteria used to choose the best model was by comparisson of r2 and AIC (Akaike Information Criteria). The model that best adjusts diclofenac tablet dissolution profile was the Hixson-Crowell cube root model.
Export Options
About this article
Cite this article as:
Monzon M. Celina, Vera-Candioti Luciana, Sarno del C. María and Delfino (h) R. Mario, Fast and Efficient Monitoring of Diclofenac Dissolution Profile by CE, Current Pharmaceutical Analysis 2014; 10 (1) . https://dx.doi.org/10.2174/157341291001140102110607
DOI https://dx.doi.org/10.2174/157341291001140102110607 |
Print ISSN 1573-4129 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-676X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Relationship between Inflammatory Mediators, Aβ Levels and ApoE Genotype in Alzheimer Disease
Current Alzheimer Research Alzheimers Disease and Non-Steroidal Anti-Inflammatory Drugs: Old Therapeutic Tools with Novel Mechanisms of Action?
Current Medicinal Chemistry - Central Nervous System Agents Pattern of Primary Vasculitis with Peripheral Ischemic Manifestations: Report of a Case Series and Role of Vascular Surgery
Current Rheumatology Reviews Oxidative-Nitrosative Stress as a Contributing Factor to Cardiovascular Disease in Subjects with Diabetes
Current Vascular Pharmacology Complement System in SLE as a Target for Antibodies
Current Rheumatology Reviews Epothilones: A Novel Class of Non-taxane Microtubule-stabilizing Agents
Current Pharmaceutical Design In Search of the Most Suitable Lentiviral shRNA System
Current Gene Therapy Update on ICOS: A Possible Target for Turning-Off Autoimmunity
Recent Patents on Endocrine, Metabolic & Immune Drug Discovery Targeting Pain-evoking Transient Receptor Potential Channels for the Treatment of Pain
Current Neuropharmacology SS31, a Small Molecule Antioxidant Peptide, Attenuates β-Amyloid Elevation, Mitochondrial/Synaptic Deterioration and Cognitive Deficit in SAMP8 Mice
Current Alzheimer Research Investigation of Isoprostanes as Potential Biomarkers for Alzheimer's Disease Using Chiral LC-MS/MS and SFC-MS/MS
Current Analytical Chemistry Patent Selections:
Recent Patents on Chemical Engineering Chronic Thromboembolic Pulmonary Hypertension-Therapeutic Options
Current Respiratory Medicine Reviews Climate Changes and Human Health: A Review of the Effect of Environmental Stressors on Cardiovascular Diseases Across Epidemiology and Biological Mechanisms
Current Pharmaceutical Design Dendritic Cell Immunotherapy for Acute Inflammatory Diseases
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry Vascular Endothelial Growth Factor (VEGF) Biochemistry and Development of Inhibitory Drugs
Current Drug Therapy Overlapping the Tryptophan Catabolite (TRYCAT) and Melatoninergic Pathways in Alzheimer's Disease
Current Pharmaceutical Design Molecular Mechanisms of Epithelial Regeneration and Neovascularization During Healing of Gastric and Esophageal Ulcers
Current Medicinal Chemistry Anti-Invasive and Anti-Metastasis Strategies: New Roads, New Tools and New Hopes
Current Cancer Drug Targets Biologically Active 4-Thiazolidinones: A Review of QSAR Studies and QSAR Modeling of Antitumor Activity
Current Topics in Medicinal Chemistry